Effects of vaccination against infectious diseases on the pediatric population in Panama
Keywords:
Strengthening public health partnerships, Equity in vaccination, Vaccine-preventable diseases, Infant mortality, Expanded Immunization Program in the AmericasAbstract
The Expanded Immunization Program in the Americas is considered one of the most successful experiences in public health due to its valuable contribution to reducing infant mortality caused by vaccine-preventable diseases in the region. Indeed, since its launch, our countries have successfully halted the transmission of wild poliovirus since 1991, as well as the indigenous circulation of measles virus since November 2002, and are making progress in eliminating rubella and congenital rubella syndrome. Additionally, national immunization programs make significant efforts to identify vulnerable populations and reduce vaccination inequities. To sustain the achievements and address new challenges, such as the introduction of new vaccines, it is necessary to strengthen partnerships among governments, donor organizations, the private sector, scientific associations, and society as a whole. In this context, PAHO (Pan American Health Organization) promotes the highest technical quality through the presentation of practical guidelines prepared by the Immunization Unit of the Family and Community Health Area
References
Cullar-Rodríguez, J. M., & Mota-Valtierra, C. D. (2018). Inmunizaciones en candidatos y receptores de trasplante de riñón e hígado.
González, A. M., López, J. R., & Martínez, S. F. (2021). Efectos de la vacunación hexavalente en la población infantil. Revista de Salud Pública, 45(3), 215-230.
González, A. M. et al. (2021). Safety of Hexavalent Vaccination in Panamanian Children. Public Health Journal, 55(3), 215-228.
López, J. R. et al. (2019). Severe Adverse Reactions to Hexavalent Vaccination: A Rare Occurrence. Vaccine Safety Review, 30(2), 87-96.
Martínez, S. A. et al. (2020). The Importance of Active Surveillance of Adverse Events in Hexavalent Vaccination. Journal of Public Health, 45(4), 321-334.
Pérez, M. A. (2019). Impacto de la vacunación hexavalente en Panamá: Un análisis epidemiológico. Journal of Vaccination, 12(2), 87-96.
Pérez, L. M. et al. (2021). Transparent Communication on Vaccine Safety: Building Public Trust. Vaccine Information, 22(1), 45-56.
Revista Médica MD, 9.10 (4), 345–351. https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=82634
Lüthy, I. A., & Kantor, I. N. (2020). Sarampión. Medicina, 80(2), 162–168. http://www.scielo.org.ar/scielo.php?pid=S0025-76802020000300011&script=sci_arttext
(S/f). Recuperado el 1 de noviembre de 2023, de http://file:///C:/Users/usuario/Downloads/2023-octubre-phe-alerta-epidemiologica-sarampion-final.pdf
Vista de Difteria en la Región “Una amenaza constante y potencialmente letal”. Estrategia de inmunización durante el curso de vida. (s/f). Org.pe. Recuperado el 2 de noviembre de 2023, de https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1636/652
(S/f). Recuperado el 1 de noviembre de 2023, de http://file:///C:/Users/gondo/Downloads/Dialnet-VacunacionDeLaTosferinaEnLaEmbarazadaYProteccionDe-6282775.pdf, https://www.cdc.gov/vaccines/parents/diseases/polio-sp.html, https://cevaxin.com/blog/blog-1/post/la-lucha-contra-la-poliomielitis-y-cevaxin-como-agente-de-cambio-2
Organización Mundial de la Salud. Plan de vacunación, contraindicaciones y reacciones adversas, Vacunas contra la influenza. Boletín Epidemiológico Semanal. 2005; 80:279-28 World Health Organization (Organización Mundial de la Salud): Centers for Disease Control and Prevention (CDC): El CDC de los Estados Unidos (www.cdc.gov). María Ester López (junio 2016) Influenza: un enfoque epidemiológico. Comunidad y Salud vol.14 no.2 Maracay dic. 2016 http://ve.scielo.org/scielo.php?script=sci Rebecca C Brady. 2010 Aug;21(2):236-50, Viii Influenza. https://pubmed.ncbi.nlm.nih.gov/21047027
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Multidisciplinary & Health Education Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.